[Analysis of the use of prostate specific antigen (PSA) in a health area of the Community of Madrid].
To approach the local extent of PSA-use, and to check its yield in terms of prostate cancer (PC) detection. All PSA-test records (1997-1999) were reviewed and testing rates calculated per 1000 person-years. Detection rate (PC) was also estimated and referred to our PC prevalence study using the odds ratio as instrument for comparison. Testing rate in the general population was 21.6/1000 person-years. PC detection rate was 1.76% (1.28 inside the prevalence study). For every CP detected in the general population with a PSA ranging 4-10 ng/ml, 2.39 (OR = 2.39) were detected in the prevalence study (OR = 4.48 for the PSA range > 10 ng/ml). PSA-testing in our setting is high. PC detection rates were lower than expected.